Overall, these data suggest that host Tregs, enriched in tumor Ag-specific cells, generated/expanded during tumor development participate in the induction of anergy and the conversion of newly arriving tumor Ag-specific naive CD4+ T cells into pTregs in the TdLN. The gene discussed is CD4; the disease is neoplasm.